Everdime Technologies, Inc.
RGST · OTC
3/31/2024 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $25 | $37 | $37 | $47 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $26 | $38 | $38 | $47 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 55.9% | – | 100% | – |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 22.7% | – | 2.9% | – |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | 16% | – | 2.6% | – |
| EPS Diluted | 0 | -0.001 | 0 | -0.003 |
| % Growth | 160% | -3,253.3% | 100.6% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |